Tip: I/OCE update brings new APCs
APCs Insider, June 6, 2014
Want to receive articles like this one in your inbox? Subscribe to APCs Insider!
Two APCs were added with an effective date of January 1, 2014, and assigned status indicator K (non-pass-through drugs and non-implantable biologicals, including therapeutic radiopharmaceuticals):
- 01477, injection, tbo-filgrastim, 5 mcg
- 01478, human fibrinogen concentrate injection
CMS also added two APCs with an effective date of April 1, 2014, with status indicator G (pass-through drugs and biologicals):
- 01476, injection, obinutuzumab
- 01479, TheraSkin
CMS deleted APC 01645 (I131 tositumomab, rx) effective April 1, 2014.
This tip is adapted from “CMS refines skin substitute packaging” in the June issue of Briefings on APCs.
Want to receive articles like this one in your inbox? Subscribe to APCs Insider!
Related Products
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Note similarities and differences between HCPCS, CPT® codes
- CDC alert: Screen for international travel as Ebola cases increase
- Q&A: Primary, principal, and secondary diagnoses
- Complications from immobility by body system
- Differentiate between types of wound debridement
- Nursing responsibilities for managing pain
- Practice the six rights of medication administration
- OB services: Coding inside and outside of the package
- The consequences of an incomplete medical record
- E-mailed
-
- CDC alert: Screen for international travel as Ebola cases increase
- Capturing start and stop times for infusions
- Differentiate between types of wound debridement
- Performing a SWOT analysis
- Life Safety Code Q&A: Ambulatory care soiled utility room
- Leadership training for charge nurses
- Helping Charge Nurses understand their leadership role (Part 2 of 3)
- Five ways to safeguard your patients' valuables
- Developing a Fall-Prevention Program
- Coding, billing, and documentation tips for teaching physicians, interns, residents, and students
- Searched